FDA Expands Market Access, Authorizes New ENDS Products
http://www.fda.gov/news-events/press-announcements/fda-expands-market-access-authorizes-new-ends-products

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/sizing-catheter-recall-cook-medical-removes-various-centimeter-sizing-catheters

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/surgical-stapler-reload-recall-intuitive-surgical-removes-8mm-sureform-30-gray-reloads

FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug
http://www.fda.gov/news-events/press-announcements/fda-permits-expanded-access-investigational-pancreatic-cancer-drug

FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
http://www.fda.gov/news-events/press-announcements/fda-approves-first-non-antipsychotic-drug-treat-agitation-associated-dementia

FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List
http://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list

http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/insulin-pump-recall-insulet-removes-certain-omnipod-5-pods

FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.
http://www.fda.gov/news-events/press-announcements/fda-releases-results-largest-ever-testing-infant-formula-us

FDA Announces Major Steps to Implement Real-Time Clinical Trials
http://www.fda.gov/news-events/press-announcements/fda-announces-major-steps-implement-real-time-clinical-trials